Clendeninn, Neil J.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

The Pharmacology and Clinical Use of Methotrexate

Cowan, Kenneth H., Curt, Gregory A., Clendeninn, Neil J., Chabner, Bruce A., Jolivet, Jacques

Journal:

Boston Medical and Surgical Journal

Year:

1983

Language:

english

File:

PDF, 4.05 MB

english, 1983

2

Ontological development of opiate receptors in rodent brain

Neil J. Clendeninn, Michelle Petraitis, Eric J. Simon

Journal:

Year:

1976

Language:

english

File:

PDF, 179 KB

english, 1976

3

Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three days

Howard Bailey, Peter Kohler, Richard Tuttle, Paul P. Carbone, John A. Hohneker, Neil J. Clendeninn, George Wilding

Journal:

Investigational New Drugs

Year:

1992

Language:

english

File:

PDF, 717 KB

english, 1992

4

Safety, Pharmacokinetics, and Antiretroviral Activity of the Potent, Specific Human Immunodeficiency Virus Protease Inhibitor Nelfinavir: Results of a Phase I/II Trial and Extended Follow-up in Patients Infected with Human Immunodeficiency Virus

Moyle, Graeme J., Youle, Michael, Higgs, Chris, Monaghan, Jo, Prince, William, Chapman, Sharon, Clendeninn, Neil, Nelson, Mark R.

Journal:

Journal of Clinical Pharmacology

Year:

1998

Language:

english

File:

PDF, 1.24 MB

english, 1998

5

Phase II trial of nolatrexed dihydrochloride [ThymitaqTM, AG 337] in patients with advanced hepatocellular carcinoma

Minaxi Jhawer, Lee Rosen, Janet Dancey, Howard Hochster, Solomon Hamburg, Margaret Tempero, Neil Clendeninn, Sridhar Mani

Journal:

Investigational New Drugs

Year:

2007

Language:

english

File:

PDF, 279 KB

english, 2007

6

A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer

Everett E. Vokes, Isaiah W. Dimery, Charlotte D. Jacobs, Daniel Karp, Arturo Molina, Mary A. Collier, Melody L. Eble, Neil J. Clendeninn

Journal:

Year:

1991

Language:

english

File:

PDF, 468 KB

english, 1991

7

Matrix Metalloproteinase Inhibitors in Cancer Therapy ||

Clendeninn, Neil J., Appelt, Krzysztof

Year:

2001

Language:

english

File:

PDF, 28.58 MB

english, 2001

8

Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion

Richard L. Schilsky, Mark J. Ratain, Linda Janisch, Nicholas J. Vogelzang, V. Sol Lucas, Joshua Ravitch, John A. Hohneker, Neil J. Clendeninn, Richard L. Tuttle

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1993

Language:

english

File:

PDF, 703 KB

english, 1993

9

Initial clinical trial and pharmacokinetics of ThymitaqTM (AG337) by 10-day continuous infusion in patients with advanced solid tumors

Patrick J. Creaven, Lakshmi Pendyala, Neal J. Meropol, Neil J. Clendeninn, Ellen Y. Wu, Gregory M. Loewen, April Proefrock, Amanda Johnston, Mary Dixon

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1997

Language:

english

File:

PDF, 135 KB

english, 1997

10

Hypersensitivity and infusion-site adverse events with intravenous fosaprepitant after anthracycline-containing chemotherapy: a retrospective study

Boccia, Ralph, Geller, Robert B, Clendeninn, Neil, Ottoboni, Thomas

Journal:

Future Oncology

Year:

2018

Language:

english

File:

PDF, 1.26 MB

english, 2018

11

A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U)

Weiss, Geoffrey R., Sarosy, Gisele A., Shenkenberg, Todd D., Williams, Thomas, Clendeninn, Neil J., von Hoff, Daniel D., Woolley, Joseph L., Liao, Sam H.T., Robert Blum, M.

Journal:

European Journal of Cancer and Clinical Oncology

Year:

1989

Language:

english

File:

PDF, 674 KB

english, 1989

12

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

Wu-Ching Uen, Andrew T. Huang, Robert Mennel, Stephen E. Jones, Monica B. Spaulding, Kathleen Killion, Kathleen Havlin, Patricia Keegan, Neil J. Clendeninn

Journal:

Year:

1992

Language:

english

File:

PDF, 347 KB

english, 1992

13

Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder

Masoud Khorsand, Joan Lange, Lynn Feun, Neil J. Clendeninn, Mary Collier, George Wilding

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 45 KB

english, 1997

14

Potential Pitfalls in the Evaluation of the Usefulness of Hemodialysis for the Removal of Lithium

Clendeninn, Neil J., Pond, Susan M., Kaysen, George, Barraza, Jaime J., Farrell, Thomas, Becker, Charles E.

Journal:

Clinical Toxicology (Informa Healthcare)

Year:

1982

Language:

english

File:

PDF, 526 KB

english, 1982

15

Matrix Metalloproteinase Inhibitors in Cancer Therapy || Research on MMP Inhibitors with Unusual Scaffolds

Clendeninn, Neil J., Appelt, Krzysztof

Year:

2001

Language:

english

File:

PDF, 1.97 MB

english, 2001

16

Phase II Trial of Piritrexim and DTIC Using an Alternating Dose Schedule in Metastatic Melanoma

Feun, Lynn G., Robinson, William A., Savaraj, Niramol, Gonzalez, R., Liebmann, Amy, Offenhauser, Karen, Clendeninn, Neil J.

Journal:

American Journal of Clinical Oncology

Year:

1995

File:

PDF, 186 KB

1995

17

Oral piritrexim — A phase II study in patients with advanced soft tissue sarcoma

Judith D. Schiesel, Matthew Carabasi, Gordon Magill, Ephraim Casper, Edgar Cheng, Linda Marks, Jan Feyzi, Neil J. Clendeninn, Richard V. Smalley

Journal:

Investigational New Drugs

Year:

1992

Language:

english

File:

PDF, 129 KB

english, 1992

18

A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma

Jordan Berlin, A. Christie King, Kendra Tutsch, John W. Findlay, Peter Kohler, Mary Collier, Neil J. Clendeninn, George Wilding

Journal:

Investigational New Drugs

Year:

1994

Language:

english

File:

PDF, 447 KB

english, 1994

19

Predictors of optimal virological response to potent antiretroviral therapy

Powderly, William G., Saag, Michael S., Chapman, Sharon, Yu, George, Quart, Barry, Clendeninn, Neil J.

Journal:

Year:

1999

Language:

english

File:

PDF, 150 KB

english, 1999

20

Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation

Ottoboni, Thomas, Keller, Mary Rose, Cravets, Matt, Clendeninn, Neil, Quart, Barry

Journal:

Drug Design Development and Therapy

Year:

2018

Language:

english

File:

PDF, 1.84 MB

english, 2018

21

Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects

Ottoboni, Tom, Lauw, Michael, Keller, Mary Rose, Cravets, Matt, Manhard, Kimberly, Clendeninn, Neil, Quart, Barry

Journal:

Future Oncology

Year:

2018

Language:

english

File:

PDF, 1.48 MB

english, 2018

22

A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)-l Protease, to Treat HIV Infection

Martin Markowitz, Marcus Conant, Arlene Hurley, Rosemary Schluger, Margarita Duran, Joanna Peterkin, Sharon Chapman, Amy Patick, Amy Hendricks, Geoffrey J. Yuen, William Hoskins, Neil Clendeninn and D

Journal:

The Journal of Infectious Diseases

Year:

1998

Language:

english

File:

PDF, 1.41 MB

english, 1998

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски